Drugs News and Research

RSS

Zika outbreak highlights need for developing and evaluating new vaccines for pregnant women

The recent outbreak of Zika virus disease and its link to fetal development highlights the need for pregnant women and those of reproductive age to be a priority group for developing and evaluating new vaccines and vaccine guidelines for Zika and other emerging infectious diseases, say the authors of a new Viewpoint article in JAMA.

25 Feb 2016

Stop TB Partnership's new initiative to increase access to two new life-saving TB medicines

The Stop TB Partnership's Global Drug Facility (GDF) will announce a new initiative to increase access to bedaquiline and delamanid - the two new life-saving medicines recently approved for the treatment of multi-drug resistant tuberculosis (TB). The GDF will share how it is expanding existing and developing new public-private partnerships to expedite and maximize access to these two critical medicines.

25 Feb 2016

Investigating mechanism behind development of high-grade serous ovarian cancer

Rutgers Cancer Institute of New Jersey researcher Michael L. Gatza, PhD, has received a $747,000 Pathway to Independence Award (R00-CA166228) from the National Cancer Institute to explore the mechanism behind the development of a subtype of ovarian cancer known as high-grade serous ovarian cancer.

24 Feb 2016

Omega-3 fatty acids can lower risk of breast cancer in postmenopausal obese women

Omega-3 fatty acids may lower the risk of breast cancer in postmenopausal obese women, according to researchers.

24 Feb 2016

Doctors use supercomputers to create 3D models from heart disease patients

University of Melbourne doctors and engineers are using supercomputers to create 3D models from patients with heart disease, with photos from a camera thinner than a human hair.

24 Feb 2016

Asterias announces successful completion of End-of-Phase 2 meeting with FDA for AML therapy

Asterias Biotherapeutics, Inc. today announced the successful completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration for AST-VAC1, its investigational therapy targeting acute myeloid leukemia (AML).

24 Feb 2016

PolyPid closes $22 million private equity financing

PolyPid Ltd., an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, announced today that it closed a $22 million private equity financing.

24 Feb 2016

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

24 Feb 2016

UEA research paves way for new wave of drugs to kill superbugs

Scientists at the University of East Anglia are getting closer to solving the problem of antibiotic resistance.

24 Feb 2016

Ohio State researchers working on new way to treat drug-resistant cancer

Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of--only it's not a Trojan horse, but DNA that hides the invading force.

24 Feb 2016

Single dose of zoledronic acid can inhibit bone loss in HIV-infected patients

A single dose of the drug zoledronic acid was found to inhibit the bone loss that is common in HIV-infected patients and that is increased during the first two years of treatment with antiretroviral therapy (ART).

24 Feb 2016

Longer, more intense period of rehabilitation may boost recovery after stroke or traumatic injury

Cognitive and functional recovery after a stroke or traumatic injury requires intense rehabilitative therapy to help the brain repair and restructure itself. New findings by researchers at University of California, San Diego School of Medicine report that not only is rehabilitation vital - in an animal model, rats with cortical injury that did not receive intensive rehab did not rebuild brain structure or recover function - but that a longer, even more intense period of rehabilitation may produce even greater benefit.

23 Feb 2016

ARV drug atazanavir may have significant effects on infant development

The antiretroviral (ARV) drug atazanavir—sometimes included in treatments to prevent mother-to-child HIV transmission during pregnancy—may have small but significant effects on infant development, reports a study in the journal AIDS, official journal of the International AIDS Society.

23 Feb 2016

MDI Biological Laboratory scientist identifies potential drug therapy to reverse peripheral nerve damage

The Mount Desert Island Biological Laboratory has announced that assistant professor Sandra Rieger, Ph.D., has identified two drugs that could potentially be used to reverse peripheral nerve damage, or peripheral neuropathy, resulting from chemotherapy treatment for ovarian, breast, lung, pancreas and other cancers. The drugs also have potential applications for the treatment of peripheral nerve damage caused by diabetes, traumatic injuries and other conditions.

23 Feb 2016

Giving feedbacks to GPs could cut unnecessary prescriptions of antibiotics

Sending general practitioners (GPs) in England a letter giving feedback on their antibiotic prescribing habits could cut unnecessary prescriptions of antibiotics, according to the first nationwide randomised trial of its kind involving over 1500 GP practices, published in The Lancet.

23 Feb 2016

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

Reporting on the results of a phase III international clinical trial, Johns Hopkins Medicine physicians say use of a cardiac clot-busting drug to treat strokes that cause brain bleeding safely decreased the death rate in patients by 10 percent, compared to a control group receiving saline.

23 Feb 2016

Drugs News and Research

Zika outbreak highlights need for developing and evaluating new vaccines for pregnant women

Stop TB Partnership's new initiative to increase access to two new life-saving TB medicines

Investigating mechanism behind development of high-grade serous ovarian cancer

Omega-3 fatty acids can lower risk of breast cancer in postmenopausal obese women

Doctors use supercomputers to create 3D models from heart disease patients

Asterias announces successful completion of End-of-Phase 2 meeting with FDA for AML therapy

PolyPid closes $22 million private equity financing

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

UEA research paves way for new wave of drugs to kill superbugs

Ohio State researchers working on new way to treat drug-resistant cancer

Single dose of zoledronic acid can inhibit bone loss in HIV-infected patients

Longer, more intense period of rehabilitation may boost recovery after stroke or traumatic injury

ARV drug atazanavir may have significant effects on infant development

MDI Biological Laboratory scientist identifies potential drug therapy to reverse peripheral nerve damage

Giving feedbacks to GPs could cut unnecessary prescriptions of antibiotics

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

New clinical trial focuses on respiratory drug ambroxol for treatment of Parkinson's disease

Hiroshima University researchers identify new class of cancer-causing genetic variations

UA College of Pharmacy assistant professor developing dry powder inhalers to treat pulmonary diseases

UCSF study finds specific molecular-genetic mechanism that links sleep and seasonal depression

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News